Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
2004-7-5
pubmed:abstractText
The significance of beta-blockers in the treatment of cardiovascular diseases is well established. The effect of vasodilating beta-blockers on endothelial function and prothrombotic state has not been investigated.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Adrenergic beta-Antagonists, http://linkedlifedata.com/resource/pubmed/chemical/Antihypertensive Agents, http://linkedlifedata.com/resource/pubmed/chemical/Benzopyrans, http://linkedlifedata.com/resource/pubmed/chemical/Biological Markers, http://linkedlifedata.com/resource/pubmed/chemical/Carbazoles, http://linkedlifedata.com/resource/pubmed/chemical/Celiprolol, http://linkedlifedata.com/resource/pubmed/chemical/Ethanolamines, http://linkedlifedata.com/resource/pubmed/chemical/Fibrinogen, http://linkedlifedata.com/resource/pubmed/chemical/Homocystine, http://linkedlifedata.com/resource/pubmed/chemical/Plasminogen Activator Inhibitor 1, http://linkedlifedata.com/resource/pubmed/chemical/Propanolamines, http://linkedlifedata.com/resource/pubmed/chemical/carvedilol, http://linkedlifedata.com/resource/pubmed/chemical/nebivolol
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0895-7061
pubmed:author
pubmed:issnType
Print
pubmed:volume
17
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
582-9
pubmed:dateRevised
2009-2-24
pubmed:meshHeading
pubmed-meshheading:15233977-Adrenergic beta-Antagonists, pubmed-meshheading:15233977-Antihypertensive Agents, pubmed-meshheading:15233977-Benzopyrans, pubmed-meshheading:15233977-Biological Markers, pubmed-meshheading:15233977-Blood Pressure, pubmed-meshheading:15233977-Carbazoles, pubmed-meshheading:15233977-Celiprolol, pubmed-meshheading:15233977-Endothelium, Vascular, pubmed-meshheading:15233977-Ethanolamines, pubmed-meshheading:15233977-Female, pubmed-meshheading:15233977-Fibrinogen, pubmed-meshheading:15233977-Homocystine, pubmed-meshheading:15233977-Humans, pubmed-meshheading:15233977-Hypertension, pubmed-meshheading:15233977-Male, pubmed-meshheading:15233977-Middle Aged, pubmed-meshheading:15233977-Plasminogen Activator Inhibitor 1, pubmed-meshheading:15233977-Propanolamines, pubmed-meshheading:15233977-Smoking, pubmed-meshheading:15233977-Treatment Outcome, pubmed-meshheading:15233977-Vasodilation
pubmed:year
2004
pubmed:articleTitle
The impact of third-generation beta-blocker antihypertensive treatment on endothelial function and the prothrombotic state: effects of smoking.
pubmed:affiliation
First Cardiology Department of Athens University, Hippokration Hospital, Athens, Greece.
pubmed:publicationType
Journal Article, Comparative Study